Mission Therapeutics Appoints Dr Anne Phelan as Senior Vice President, Head of Discovery Research
CAMBRIDGE, UK – 20 March 2017 – Mission Therapeutics, a drug discovery and development company focused on selectively targeting deubiquitylating enzymes (DUBs) to treat cancer, neurodegenerative and other diseases, announced the appointment of Dr Anne Phelan as Senior Vice President, Head of Discovery Research, effective 20 March 2017. Dr Phelan has spent over 20 years […]